Simcere Pharmaceutical Group Limited

HKEX:2096.HK

6.23 (HKD) • At close September 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 1,614.2381,614.2381,689.6651,689.6651,812.2161,812.2161,349.8251,349.8251,439.8581,439.8581,060.0011,060.0011,291.6541,291.654962.707962.7071,311.3181,311.3181,207.0121,207.012421.301482.995528.729540.14504.715645.219600.82
Cost of Revenue 402.812402.812409.015409.015385.017385.017278.686278.686311.503311.503228.489228.489255.899255.899194.065194.065242.185242.185202.058202.058101.06881.54110.047101.93579.933103.867108.232
Gross Profit 1,211.4271,211.4271,280.651,280.651,427.21,427.21,071.141,071.141,128.3551,128.355831.513831.5131,035.7551,035.755768.642768.6421,069.1331,069.1331,004.9541,004.954320.233401.455418.682438.205424.782541.352492.588
Gross Profit Ratio 0.750.750.7580.7580.7880.7880.7940.7940.7840.7840.7840.7840.8020.8020.7980.7980.8150.8150.8330.8330.760.8310.7920.8110.8420.8390.82
Reseach & Development Expenses 402.667402.667387.946387.946545.866545.866325.769325.769403.668403.668313.402313.402352.633352.633227.046227.046239.729239.729126.266126.26647.5245.1544.9360.21664.67367.06359.497
General & Administrative Expenses 121.323121.323128.317128.317128.798128.79894.24194.241101.59101.5981.73981.739109.006109.00696.73296.73298.03998.03977.877.866.12865.31464.01274.38458.21768.0280.192
Selling & Marketing Expenses 554.542554.542623.651623.651686.715686.715514.668514.668603.264603.264415.089415.089470.936470.936314.251314.251489.677489.677518.434518.434206.766280.277259.557284.518300.208355.556318.877
SG&A 675.901675.901751.499751.499818.543818.543598.892598.892692.95692.95516.645516.645579.942579.942410.983410.983587.716587.716596.234596.234272.894345.591323.569358.902358.425423.576399.07
Other Expenses 000000000000000000000000000
Operating Expenses 2,007.8052,007.805124.449124.4491,017.191,017.191,050.7511,050.751696.787696.787560.902560.902726.2726.2621.912621.912782.643782.643709.92709.92220.555398.793379.188507.14400.546-494.082-437.458
Operating Income 175.991175.991179.429179.429113.126113.126190.045190.04583.86683.86632.80132.801147.807147.807152.149152.149287.028287.028290.657290.657-0.18110.71450.183-21.3521.68450.71253.305
Operating Income Ratio 0.1090.1090.1060.1060.0620.0620.1410.1410.0580.0580.0310.0310.1140.1140.1580.1580.2190.2190.2410.241-00.0220.095-0.040.0030.0790.089
Total Other Income Expenses Net -968.563-968.563983.163983.163303.74303.74-163.784-163.784356.113356.113228.119228.119142.371142.371-39.783-39.783-21.192-21.192-15.585-15.58594.581-18.022-22.922-60.2247.843-26.005-21.996
Income Before Tax -792.573-792.5731,162.5921,162.592416.866416.86626.26226.262439.979439.979260.92260.92290.178290.178112.367112.367265.836265.836275.072275.07294.4-7.30827.261-81.5769.52724.70831.31
Income Before Tax Ratio -0.491-0.4910.6880.6880.230.230.0190.0190.3060.3060.2460.2460.2250.2250.1170.1170.2030.2030.2280.2280.224-0.0150.052-0.1510.0190.0380.052
Income Tax Expense 12.62912.62925.67325.67315.5415.544.6994.69932.03532.03516.52816.52850.45250.45219.94919.9495.4735.47344.56844.5685.77610.316.50611.9193.2070.3123.249
Net Income -779.944-779.9441,137.3241,137.324433.542433.54231.89231.892474.641474.641278.907278.907242.008242.00892.75992.759271.308271.308230.504230.504166.9598.22829.943-20.815.98932.91735.27
Net Income Ratio -0.483-0.4830.6730.6730.2390.2390.0240.0240.330.330.2630.2630.1870.1870.0960.0960.2070.2070.1910.1910.3960.0170.057-0.0390.0320.0510.059
EPS -0.3-0.30.430.430.170.170.010.010.180.180.110.110.0990.0990.040.040.120.120.0980.0981.550.0780.28-0.20.150.310.32
EPS Diluted -0.3-0.30.430.430.170.170.0120.0120.180.180.110.110.0990.0990.040.040.120.120.0980.0981.550.0770.28-0.20.150.30.32
EBITDA 228.569228.569233.993233.993165.404165.404242.285242.285129.509129.50981.71881.718189.414189.414189.86189.86320.937320.937309.657309.65732.71543.6183.07911.54432.24788.00990.964
EBITDA Ratio 0.1420.1420.1380.1380.0910.0910.1790.1790.090.090.0770.0770.1470.1470.1970.1970.2450.2450.2570.2570.0780.090.1570.0210.0640.1360.151